---
title: "SNEE Covid-19 Oral Antiviral Treatment Service"
ocid: "ocds-h6vhtk-047bf0"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-047bf0"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-047bf0.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-047bf0.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "NHS SUFFOLK AND NORTH EAST ESSEX ICB"
published: "2024-07-22"
---

# SNEE Covid-19 Oral Antiviral Treatment Service

Buyer: NHS SUFFOLK AND NORTH EAST ESSEX ICB  
Current stage: Award  
OCID: ocds-h6vhtk-047bf0

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-047bf0)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-047bf0.json)

## Summary

NHS Suffolk and North East Essex ICB has recently concluded the award stage of their "SNEE Covid-19 Oral Antiviral Treatment Service" contract. This procurement falls within the health services category, specifically targeting Covid-19 oral antiviral treatments for non-hospitalised patients in Suffolk and North East Essex. The procurement method used was a direct award under the Health Care Services (Provider Selection Regime) Regulations 2023, with the contract formally awarded on 27th June 2024. The service period extends from 27th June 2024 to 31st March 2025, and the contract’s total value excluding VAT is anticipated to be £8,550.00. Additionally, significant providers including Boots, Belstead Hills Pharmacy, and several others were selected to participate in delivering this service.

This tender offers a substantial opportunity for both large and small healthcare businesses, particularly those specialising in pharmaceutical services and community healthcare delivery. Businesses with a robust capacity to maintain stock levels and ensure rapid distribution of antiviral medications are well-suited for this contract. The service requirements emphasize prompt access and efficient management, making it ideal for pharmacies and healthcare providers that can swiftly adapt to local demands and ensure seamless integration with the SNEE Covid Management Delivery Unit (CMDU). Providers involved will benefit from a structured demand for antiviral treatments, which can support business growth and service expansion within the healthcare sector.

## Notice

The aim of this service is to provide the clinical infrastructure to support the safe, timely and appropriate dispensing of antiviral medication for the treatment of Covid-19 for non-hospitalised patients across Suffolk and North East Essex. The service is designed to ensure choice and prompt access to these medicines in the community setting for eligible patients when they are required at all times whilst the pharmacies are open. Each provider will stock a minimum of THREE packs of each antiviral medication (or higher based on local demand) and will make a commitment to ensure eligible patients have prompt access to these medicines to facilitate treatment within 5 days of the onset of symptoms. Patients will receive a full clinical review by a SNEE Covid Management Delivery Unit (CMDU) prescriber and if eligible for treatment, an EPS prescription will be sent to the commissioned community pharmacy, in line with the consent and choice of the patient. Pharmacists will contact the patient as soon as possible upon receipt of the prescription to confirm consent and clinical suitability for treatment. This discussion is recorded on an electronic platform confirming all checks have been performed to confirm appropriateness of treatment. As appropriate, the pharmacy will make arrangement with the patient/carer for the medication to be collected or delivered.

### Lot Information

Lot 1

The aim of this service is to provide the clinical infrastructure to support the safe, timely and appropriate dispensing of antiviral medication for the treatment of Covid-19 for non-hospitalised patients across Suffolk and North East Essex. The service is designed to ensure choice and prompt access to these medicines in the community setting for eligible patients when they are required at all times whilst the pharmacies are open. Each provider will stock a minimum of THREE packs of each antiviral medication (or higher based on local demand) and will make a commitment to ensure eligible patients have prompt access to these medicines to facilitate treatment within 5 days of the onset of symptoms. Commissioned pharmacies will be required to report stockholding to the ICB on a monthly basis for ongoing assurance. Patients will receive a full clinical review by a SNEE Covid Management Delivery Unit (CMDU) prescriber and if eligible for treatment, an EPS prescription will be sent to the commissioned community pharmacy, in line with the consent and choice of the patient. Pharmacists will contact the patient as soon as possible upon receipt of the prescription to confirm consent and clinical suitability for treatment. This discussion is recorded on an electronic platform confirming all relevant clinical and pharmaceutical compatibility checks have been performed to confirm appropriateness of treatment. If necessary, the community pharmacist will contact the prescriber to clarify clinical concerns and/or in the event of stock availability issues. Otherwise, as appropriate, the pharmacy will make arrangement with the patient/carer for the medication to be collected or delivered. Deliveries of medication are expected to be in exceptional circumstances but can be arranged and remunerated under this service. The current contract period was 27-06-2023 to 26-06-2024 with no option to extend. This is an extension for 9 months of that original contract. NHS Suffolk and North East Essex Integrated Care Board are awarding the contract named within this notice under the Direct Award C process which is outlined within the Health Care Services (Provider Selection Regime) Regulations 2023. The provider named in this notice is an existing provider and has been reviewed through a Key Criteria assessment to ensure the awarding body is satisfied with current performance and reasonably expects the provider to be able to satisfy the contract which is the subject of this notice. The contract which is the subject of this notice has not changed considerably when compared with the existing / previous contract delivered by the named provider. The ICB may wish to introduce additional services during the lifetime of the contract ("Contract modifications"). Such contract modifications will be contemplated where additional requirements are similar and or complementary to the services already included in the Specification, at any given time. Such expansion would be by the addition of services commissioned by the Authority as named in the Contract Notice. To this end, after the award of contract, there is a possibility that the contract may be varied as allowable in accordance with the Health Care Services (Provider Selection Regime) Regulations 2023. Additional information: The existing provider is satisfying the original contract and will likely satisfy the proposed contract to a sufficient standard.

### Procurement Information

This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to the relevant authority by 19th July 2024. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/022615-2024 |
| Notice type | Tender Notice |
| Procurement type | Standard |
| Procurement category | Services |
| Procurement method | Limited |
| Procurement method details | Award procedure without prior publication of a call for competition |
| Tender suitability | Not specified |
| Awardee scale | Large, SME |
| All stages | Tender, Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 22 Jul 2024 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 26 Jun 2024 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | £475 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Cancelled |
| Awards status | Active |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | NHS SUFFOLK AND NORTH EAST ESSEX ICB |
| Locality | COLCHESTER |
| Post town | Colchester |
| Postcode | CO4 9QR |
| Country | England |
| ITL 1 | TLH East (England) |
| ITL 2 | TLH3 Essex |
| ITL 3 | TLH34 Essex Haven Gateway |
| Local authority | Colchester |
| Electoral ward | Highwoods |
| Westminster constituency | Colchester |
| Delivery location | TLH14 Suffolk CC, TLH34 Essex Haven Gateway |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 16 |
| Supplier names | BELSTEAD HILLS PHARMACY; BOOTS; CAVALRY ROAD PHARMACY; FRAMLINGHAM PHARMACY; GUILDHALL PHARMACY; HOLLAND PHARMACY; ISLAND PHARMACY; LONG MELFORD PHARMACY; LORDS PHARMACY; MANOR COURT PHARMACY; MARTLESHAM PHARMACY; QUEEN STREET PHARMACY; WALTON PHARMACY; WICKHAM MARKET PHARMACY; WOODBRIDGE ROAD PHARMACY; WOOLPIT HEALTH CENTRE |

## CPV Codes

### Divisions

- 85 - Health and social work services

### Codes

- 85100000 - Health services

## Release History

- 22 Jul 2024 at 09:07 - TenderUpdate - Tender Notice - https://www.find-tender.service.gov.uk/Notice/022615-2024
- 9 Jul 2024 at 13:32 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/020928-2024

## Notice URLs

- https://in-tendhost.co.uk/snee-icb/aspx/Home
- https://suffolkandnortheastessex.icb.nhs.uk/

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-047bf0. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-047bf0.json.